GHRP-2 peptide vial
📈 Growth Hormone

GHRP-2

Growth Hormone Releasing Peptide-2

Also called GHRP-2, pralmorelin, KP-102

A growth hormone releaser used in Japan as a diagnostic test

GHRP-2 is a ghrelin-receptor agonist that, in pharmacology studies, released more growth hormone than GHRP-6 with less hunger. As pralmorelin it is approved in Japan as a diagnostic test of pituitary function, which is more official standing than most peptides here. It is not approved in the US.

A second-generation six-amino-acid ghrelin-receptor agonist. In pharmacology studies it produced a larger growth hormone release than GHRP-6 with less appetite stimulation, and still raised prolactin and cortisol somewhat. Under the name pralmorelin it is approved in Japan as a diagnostic test of pituitary function; it is not approved in the US.

Half-life
About 15 to 60 minutes
Route studied
Intravenous, subcutaneous, intranasal (studies)
Status
Not FDA-approved
Moderate Evidence

Studied in people, and well studied in preclinical models

What GHRP-2 has been studied for

The reasons people look it up, roughly in order of how often, and what research exists for each. Interest in a use is not evidence that it works; the evidence is stated under each one.

Raising growth hormone
Pharmacology studies measured larger growth hormone releases than with GHRP-6, with less appetite stimulation. No trial has tested it for body composition or recovery.
Testing pituitary function
Its approved use in Japan, as pralmorelin: a single dose is given under medical supervision and growth hormone measured, to see whether the pituitary can respond.
Combined with GHRH in physiology studies
In physiology studies, GHRP-2 given with GHRH released more growth hormone than either alone, because the two act through different receptors. That is a research finding, not a tested treatment.

Mechanism of Action

How GHRP-2 works

GHRP-2 drives growth hormone release through the ghrelin/GHS-R1a pathway:

  • Ghrelin receptor (GHS-R1a) activation. It binds the growth hormone secretagogue receptor on the pituitary's growth-hormone-making cells and triggers a release, larger than GHRP-6 in comparative studies.
  • A milder appetite signal. It still mimics ghrelin, but the hunger response in studies was milder than with GHRP-6.
  • Secondary hormones. It raised prolactin, cortisol and ACTH somewhat, more at higher doses, though less than GHRP-6.
  • Interaction with GHRH. Because it acts on a different receptor from GHRH, the two together released more growth hormone than either alone in physiology studies.

GHRP-2 side effects: what studies reported

In pharmacology studies it raised cortisol and prolactin less than GHRP-6 and hexarelin and more than ipamorelin.

Most commonly reported

  • Increased appetite, milder than GHRP-6
  • A head rush
  • Tiredness
  • Puffiness
  • Injection-site redness

Worth keeping an eye on

  • Some rise in cortisol and prolactin at higher doses
  • Tingling hands from fluid retention
  • Blood sugar drifting up, as with anything raising growth hormone

Source: Clinical diagnostic use plus reports outside trials. This is a summary of published findings, not a complete safety profile and not medical advice. Questions about GHRP-2 belong with a licensed clinician who knows your history.

Your Genetics & GHRP-2

The genes involved in how GHRP-2 works

GHRP-2 works through the receptors these genes build, and the genes vary from person to person. Researchers have linked some of that variation to differences in how people respond. A DNA report tells you which versions you carry.

Chromosome 3Ghrelin receptor sensitivity

GHSR · ••

Builds the ghrelin receptor GHRP-2 acts on. Variants have been studied for their association with appetite and body weight. No study has tested whether they change response to GHRP-2.

Chromosome 5Growth hormone receptor (d3/fl polymorphism)

GHR · ••

The exon 3 deletion produces a shorter growth hormone receptor that some human studies, mostly of approved growth hormone in children, associated with greater sensitivity. It has not been studied with GHRP-2.

Chromosome 3Endogenous ghrelin (Leu72Met)

GHRL · ••

The Leu72Met variant has been associated with differences in ghrelin processing, appetite and body weight in human studies. Whether it changes response to GHRP-2, which acts on the same receptor, is untested.

SSTSomatostatin (GH inhibition)

Somatostatin is the body's brake on growth hormone release. Variants in its gene are studied for their association with growth and metabolic traits. Any link to GHRP-2 is untested.

The dots after each gene are where your own result goes. Your report fills them in with the two letters you carry at that position.

Which of these variants do you carry?

Your report reads the DNA file you already have against this research.

Read my DNA, $99

Often discussed alongside

Compounds that come up next to GHRP-2 in research and discussion. Each has its own page. None of this is a suggestion to combine them.

GHRP-6

an earlier compound in the same familyModerate Evidence

Growth Hormone Releasing Peptide-6

A first-generation six-amino-acid ghrelin-receptor agonist that releases growth hormone and sharply raises appetite. It behaves much like ghrelin itself, and in pharmacology studies it raised cortisol and prolactin as well as growth hormone. It is not an approved medicine.

4

Gene variants

35+

Studies

Ipamorelin

a more selective compound in the same familyModerate Evidence

Ipamorelin Acetate

Presses the same switch the stomach uses to say it is empty, the one that also triggers a growth hormone release, but largely without the hunger. What set it apart in early pharmacology work is what it did not do: older peptides in its family also pushed up cortisol and prolactin, and this one mostly stopped at growth hormone. It is not an approved medicine.

4

Gene variants

40+

Studies

Access

Access and legal status

GHRP-2 is not an FDA-approved drug. Products sold online as “research chemicals” are labelled not for human use, and FDA treats them as unapproved drugs when they are marketed for people. We don't link to any seller, and nothing on this page is a recommendation to obtain or use it.

Your DNA and GHRP-2: see which of the variants studied alongside it you carry, and what that research does and does not show. Read my DNA, $99 →

Educational information only, not medical advice. Most peptides are not FDA-approved. Do not start, stop or change any medication or peptide because of this page; talk to a licensed clinician.

Worth knowing about GHRP-2

Interactions and situations where there is a specific reason to be careful. Where the honest answer is that nobody has studied something, it says so and says what that leaves open.

Food changes the measured response
In pharmacology studies, a meal, particularly one with fat, blunted the growth hormone response, which matters for how diagnostic tests with it are run.
Not approved in the US, and banned in sport
Outside its diagnostic approval in Japan, it is not an approved medicine, and growth hormone secretagogues are prohibited at all times under WADA rules. It also raises cortisol and prolactin somewhat.

Last updated

Frequently Asked Questions

What is the difference between GHRP-2 and GHRP-6?

Both mimic ghrelin to release growth hormone. In comparative pharmacology studies, GHRP-2 produced a larger growth hormone release with much less appetite stimulation, while GHRP-6 caused pronounced hunger. Neither is approved in the US.

Why is GHRP-2 mentioned with GHRH copies like CJC-1295?

They act on two different receptors that both lead to growth hormone release. In physiology studies, GHRP-2 given with GHRH released more growth hormone than either alone. No trial has tested GHRP-2 with CJC-1295 as a treatment.

Do genes affect GHRP-2 response?

No study has tested whether any genotype changes response to GHRP-2. GHSR, GHR, GHRL and SST build the receptors and hormones it works through, and some of their variants have been associated with appetite or growth traits in human studies. A DNA report can show which versions you carry and what that research does and does not show.

Learn more about GHRP-2

Your DNA and GHRP-2

What the research says about your variants.

The report

Which GHRP-2 variants do you carry?

Your report reads the DNA file you already have against the published research on 31 peptides, marker by marker, and says what that research does and does not show.

Read my DNA, $99
Upload your DNA